DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study

Creative Commons License

Caltekin M. D., Caniklioglu A., Yalcin S. E., Kirmizi D. A., BAŞER E., YALVAÇ E. S.

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, cilt.18, sa.2, ss.124-130, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/tjod.galenos.2021.39024
  • Dergi Adı: TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.124-130
  • Anahtar Kelimeler: Polycystic ovary syndrome, delta-like 1, nesfatin-1, visceral adiposity index, insulin resistance, INSULIN-RESISTANCE, ACTIVATION, MARKERS, OBESITY
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Objective: Delta-like 1 (DLK1) is known to inhibit adipocyte differentiation and nesfatin-1 is a neuropeptide that plays a role in the regulation of nutrition and metabolism. We aimed to assess both the levels of DLK1 and nesfatin-1 in polycystic ovary syndrome (PCOS) and determine the association of DLK1 and nesfatin-1 with metabolic parameters.